Australian orthopaedics firm works to bolster market position, files primary hip implant with FDA
This article was originally published in Clinica
Executive Summary
Less than a month after its debut on the Australian Stock Exchange (ASX), Portland Orthopaedics has moved closer to bolstering its product portfolio, after seeking US clearance for its primary hip implant product range.